Health · Pharma & Biotech · 11 hrs ago
John Oliver examines quality and supply problems with generic drugs
John Oliver used his show to examine problems with generic medicines in the United States.
Generic drugs can cost less after patents on brand-name medicines expire, but Oliver said quality checks and supply can be unreliable.
The segment described contaminated eye drops made in an Indian lab that blinded dozens of people.
It also discussed a shortage of a child’s cancer medicine after one of its two producers stopped making it because it was not profitable enough.
These problems matter because medicines can be unsafe or hard to obtain when production and business decisions affect the supply.
Oliver advised viewers to check whether their generic medicine looks different from usual and pointed them to ProPublica’s free Rx Inspector website for manufacturing information.
The segment did not describe any government or industry changes that will follow.
John Oliver examined quality-control and supply problems affecting generic drugs in a 23-minute main story.
He discussed tainted eye drops made in an uninspected Indian lab that blinded dozens of people, some of whom had to have their eyes removed.
The story highlighted how profit pressures and lax quality control can affect the supply of generic medicines.
A mother said her child’s cancer medication became unavailable after one of its two producers, Teva, decided it was not profitable enough.
Oliver advised viewers to check whether their generic medicines look the same and pointed them to ProPublica’s Rx Inspector site.
- Who
- John Oliver examined the issue; the story also described generic drug makers and a mother whose child’s cancer medication became unavailable.
- What
- The story covered quality-control and supply problems with generic drugs.
- When
- The AV Club article was published on 2026-10-12.
- Where
- The story focused on America’s drug supply and also discussed an uninspected lab in India.
- Why
- The article says profit pressures, lax quality control and market forces can affect generic drug quality and availability.
This story does not have two clearly opposing sides.
This story does not have a timeline yet.
- Main story length
- 23 minutes
- Tainted eye drops
- Made in an uninspected lab in India
- Cancer medication producers
- Two, including Teva
- ProPublica resource
- Rx Inspector website
What people are saying
It’s completely disheartening that a business decision can kill 15,000 kids a year.
one small office where a rabid bear does pull-ups all day
Sources
Related news
Bimatoprost eye lens shows early promise for cataracts and glaucoma
Italian Registry Study Finds Avacopan Appeared Effective for AAV
Merck’s eye drug meets main study goal, but results are mixed
FDA approves Asahi Kasei’s herpes treatment
Inclisiran lowered LDL cholesterol more than bempedoic acid in a trial
Bristol Myers lung drug succeeds at lower dose, but higher dose misses target
Mirum reports late-stage trial success for Livmarli in rare liver diseases
Bristol Myers reports two Phase 3 trial successes
Aficamten Improves Exercise Capacity in Nonobstructive Heart Condition Trial
GLP-1 drugs may have a role in addiction care, but questions remain
Coal tar shampoo can ease persistent dandruff and scalp psoriasis
